Table 1.
Clinical feature of NSCLC patients.
| Patient Characteristics | N (%) |
|---|---|
| Age | |
| ≤65 | 12 (55) |
| >65 | 10 (45) |
| Gender | |
| Male | 16 (73) |
| Female | 6 (27) |
| Smoking | |
| Yes | 19 (86) |
| No | 3 (14) |
| Histology | |
| Adenocarcinoma | 4 (18) |
| Sq. Cell carcinoma | 18 (82) |
| Site of metastasis | |
| Lymph nodes | 15 (68) |
| Lung | 20 (91) |
| Liver | 3 (14) |
| Brain | 4 (18) |
| Bone | 4 (14) |
| Other | 5 (23) |
| N° of affected organs | |
| 1 | 5 (23) |
| 2 | 10 (45) |
| 3 | 4 (18) |
| >3 | 2 (9) |
| cT before Nivolumab | |
| X | 1 (4) |
| 0 | 4 (18) |
| 1 | 2(9) |
| 2 | 0 |
| 3 | 6 (27) |
| 4 | 9 (41) |
| cN before Nivolumab | |
| 0 | 9 (41) |
| 1 | 11 (50) |
| 2 | 2 (9) |
| Treatment lines | |
| 2 | 20 (91) |
| >2 | 2 (9) |
| Response to Nivolumab | |
| Yes | 11 (50) |
| No | 11 (50) |